Gene and cell therapy for pancreatic cancer

INTRODUCTION: The clinical outcomes of patients with pancreatic cancer are poor, and the limited success of classical chemotherapy underscores the need for new, targeted approaches for this disease. The delivery of genetic material to cells allows for a variety of therapeutic concepts. Engineered ag...

Full description

Saved in:
Bibliographic Details
Main Authors: Singh, Hans Martin (Author) , Ungerechts, Guy (Author) , Tsimberidou, Apostolia M. (Author)
Format: Article (Journal)
Language:English
Published: 13 Jan 2015
In: Expert opinion on biological therapy
Year: 2015, Volume: 15, Issue: 4, Pages: 505-516
ISSN:1744-7682
Online Access: Get full text
Author Notes:Hans Martin Singh, MD, Guy Ungerechts, MD PhD, and Apostolia M. Tsimberidou, MD PhD

MARC

LEADER 00000caa a2200000 c 4500
001 156173473X
003 DE-627
005 20230427122024.0
007 cr uuu---uuuuu
008 170804s2015 xx |||||o 00| ||eng c
024 7 |a 10.1517/14712598.2015.1001734  |2 doi 
035 |a (DE-627)156173473X 
035 |a (DE-576)491734735 
035 |a (DE-599)BSZ491734735 
035 |a (OCoLC)1340978194 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Singh, Hans Martin  |d 1986-  |e VerfasserIn  |0 (DE-588)1077055021  |0 (DE-627)835896986  |0 (DE-576)445904542  |4 aut 
245 1 0 |a Gene and cell therapy for pancreatic cancer  |c Hans Martin Singh, MD, Guy Ungerechts, MD PhD, and Apostolia M. Tsimberidou, MD PhD 
264 1 |c 13 Jan 2015 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.08.2017 
520 |a INTRODUCTION: The clinical outcomes of patients with pancreatic cancer are poor, and the limited success of classical chemotherapy underscores the need for new, targeted approaches for this disease. The delivery of genetic material to cells allows for a variety of therapeutic concepts. Engineered agents based on synthetic biology are under clinical investigation in various cancers, including pancreatic cancer. AREAS COVERED: This review focuses on Phase I - III clinical trials of gene and cell therapy for pancreatic cancer and on future implications of recent translational research. Trials available in the US National Library of Medicine (www.clinicaltrials.gov) until February 2014 were reviewed and relevant published results of preclinical and clinical studies were retrieved from www.pubmed.gov . EXPERT OPINION: In pancreatic cancer, gene and cell therapies are feasible and may have synergistic antitumor activity with standard treatment and/or immunotherapy. Challenges are related to application safety, manufacturing costs, and a new spectrum of adverse events. Further studies are needed to evaluate available agents in carefully designed protocols and combination regimens. Enabling personalized cancer therapy, insights from molecular diagnostic technologies will guide the development and selection of new gene-based drugs. The evolving preclinical and clinical data on gene-based therapies can lay the foundation for future avenues improving patient care in pancreatic cancer. 
650 4 |a Animals 
650 4 |a Cell- and Tissue-Based Therapy 
650 4 |a cell engineering 
650 4 |a Clinical Trials as Topic 
650 4 |a Genetic Therapy 
650 4 |a Humans 
650 4 |a immunotherapy 
650 4 |a investigational 
650 4 |a oncolytic virotherapy 
650 4 |a pancreatic cancer 
650 4 |a Pancreatic Neoplasms 
700 1 |a Ungerechts, Guy  |d 1972-  |e VerfasserIn  |0 (DE-588)124557902  |0 (DE-627)363420053  |0 (DE-576)294230939  |4 aut 
700 1 |a Tsimberidou, Apostolia M.  |e VerfasserIn  |0 (DE-588)1137733985  |0 (DE-627)895096390  |0 (DE-576)491734638  |4 aut 
773 0 8 |i Enthalten in  |t Expert opinion on biological therapy  |d Abingdon : Taylor & Francis Group, 2001  |g 15(2015), 4, Seite 505-516  |h Online-Ressource  |w (DE-627)355985446  |w (DE-600)2091082-4  |w (DE-576)302969578  |x 1744-7682  |7 nnas  |a Gene and cell therapy for pancreatic cancer 
773 1 8 |g volume:15  |g year:2015  |g number:4  |g pages:505-516  |g extent:12  |a Gene and cell therapy for pancreatic cancer 
951 |a AR 
992 |a 20170804 
993 |a Article 
994 |a 2015 
998 |g 124557902  |a Ungerechts, Guy  |m 124557902:Ungerechts, Guy  |d 910000  |d 910100  |e 910000PU124557902  |e 910100PU124557902  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1077055021  |a Singh, Hans Martin  |m 1077055021:Singh, Hans Martin  |d 910000  |d 910100  |e 910000PS1077055021  |e 910100PS1077055021  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN156173473X  |e 2976301107 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 04.08.2017"],"recId":"156173473X","language":["eng"],"title":[{"title_sort":"Gene and cell therapy for pancreatic cancer","title":"Gene and cell therapy for pancreatic cancer"}],"person":[{"role":"aut","display":"Singh, Hans Martin","roleDisplay":"VerfasserIn","given":"Hans Martin","family":"Singh"},{"given":"Guy","family":"Ungerechts","role":"aut","roleDisplay":"VerfasserIn","display":"Ungerechts, Guy"},{"role":"aut","display":"Tsimberidou, Apostolia M.","roleDisplay":"VerfasserIn","given":"Apostolia M.","family":"Tsimberidou"}],"physDesc":[{"extent":"12 S."}],"relHost":[{"id":{"issn":["1744-7682"],"eki":["355985446"],"zdb":["2091082-4"]},"origin":[{"publisherPlace":"Abingdon ; London ; London","dateIssuedKey":"2001","publisher":"Taylor & Francis Group ; Ashley ; Informa Healthcare","dateIssuedDisp":"2001-"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Expert opinion on biological therapy","title":"Expert opinion on biological therapy"}],"part":{"extent":"12","text":"15(2015), 4, Seite 505-516","volume":"15","pages":"505-516","issue":"4","year":"2015"},"pubHistory":["1.2001 -"],"recId":"355985446","language":["eng"],"note":["Gesehen am 08.09.15"],"disp":"Gene and cell therapy for pancreatic cancerExpert opinion on biological therapy","type":{"bibl":"periodical","media":"Online-Ressource"}}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"13 Jan 2015"}],"id":{"doi":["10.1517/14712598.2015.1001734"],"eki":["156173473X"]},"name":{"displayForm":["Hans Martin Singh, MD, Guy Ungerechts, MD PhD, and Apostolia M. Tsimberidou, MD PhD"]}} 
SRT |a SINGHHANSMGENEANDCEL1320